Literature DB >> 3272814

Adverse effect of blood transfusion on the long-term outcome of kidney transplantation.

D Bućin1.   

Abstract

In 116 patients treated with azathioprine and prednisolone, 2-year patient survival and primary renal allograft survival was analyzed with regard to the effects of pretransplant blood transfusion and of matching for HLA-A, HLA-B, and HLA-DR. Two years after transplantation, patient survival was significantly lower in transfused patients than in non-transfused patients (81 vs. 97%, p less than 0.05). A detrimental effect of blood transfusion on graft survival was found in conjunction with HLA-A compatibility (p = 0.01 overall, and p = 0.003 for HLA-B mismatched transplants). Among transfused patients, enhanced graft survival was associated with incompatibility for HLA-A (p = 0.02 overall, and p = 0.008 for HLA-B mismatched transplants), and with compatibility for HLA-B (p = 0.0006 overall, and p = 0.005 for HLA-A mismatched transplants). The present results indicate that blood transfusion may have detrimental effect on patient survival.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3272814

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  2 in total

1.  Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance.

Authors:  Taba Kheradmand; Shusen Wang; Jane Bryant; James J Tasch; Nadine Lerret; Kathryn L Pothoven; Josetta L Houlihan; Stephen D Miller; Zheng J Zhang; Xunrong Luo
Journal:  J Immunol       Date:  2012-06-13       Impact factor: 5.422

2.  Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients.

Authors:  Vijay Subramanian; Ankit Bharat; Neeta Vachharajani; Jeffrey Crippin; Surendra Shenoy; Thalachallour Mohanakumar; William C Chapman
Journal:  HPB (Oxford)       Date:  2013-07-22       Impact factor: 3.647

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.